MedTrace Logo

PSODEEP2 Pilot Study on Koebner Induction in Psoriasis

NCT06414382 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2024-05-16

No results posted yet for this study

Summary

Patients (n=15) with skin psoriasis, minimum age 18 years, without systemic immunomodulatory treatment will be subject to Koebner induction on arms and legs given that they have given written consent and that they have self-reported Koebner.

Conditions

  • Psoriasis Vulgaris
  • Koebner Phenomenon

Interventions

OTHER

Tape-stripping

22mm tapes x 40 will be attached and removed to skin of all for limbs (tape stripping). On left arm and leg skin will also be subject to micro needling.

Sponsors & Collaborators

  • University of Copenhagen

    collaborator OTHER

  • Lund University

    collaborator OTHER

  • Skane University Hospital

    lead OTHER

Principal Investigators

  • Liv Eidsmo, Professor · Copenhagen University SIC, Karolinska Institutet

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-07
Primary Completion
2024-12-07
Completion
2025-03-07

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06414382 on ClinicalTrials.gov